How the immune system changes over time in chronic hepatitis B
Part of Digestive system, Infections clinical trials.
This study tracks how the immune system works in people with chronic hepatitis B who haven't taken antiviral medication in the last 6 months. It aims to understand the natural history of the infection without treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 1 and 80 years old
- You have been diagnosed with chronic hepatitis B (a long-term liver infection from the hepatitis B virus)
- You have not taken any antiviral medication (like pills or shots) for hepatitis B in the last 6 months
- You do not have other serious liver diseases or active infections like hepatitis C or HIV
- You do not have certain immune system disorders (like hyperthyroidism) or blood clotting problems (like diabetes or low platelets)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system changes over time in people with chronic hepatitis B. It will help doctors better understand the stages of the disease to guide treatment decisions.
This “real-life” study follows people with chronic hepatitis B to better understand their health over time. It may help researchers learn which factors affect outcomes in everyday care.
This study looks at the genes of people with chronic hepatitis B (HBV) to find why some people's immune cells (B cells and NK cells) stop working properly. The goal is to discover new ways to treat the disease.
This study looks at people with hepatitis B or C infections that have lasted more than 6 months. It aims to better understand long-term management and how treatments may help over time.
This trial is for people with chronic hepatitis B who have already cleared the virus with interferon treatment. It tests ongoing strategies to help maintain their health and prevent the virus from coming back.
This study looks at long-term outcomes in people with chronic hepatitis B who take antiviral medicines or receive interferon. It may help doctors understand which treatments work best over time and who is most likely to benefit.
Hear when a new HBV (Hepatitis B Virus) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.